Symetix announces the availability of its new white paper titled, “Final Bulk Inspection of Solid-Dose Pharmaceuticals.” Download high res photo (905 kb)

To download this new white paper, visit http://www.symetixresearch.com/whitepaper/Default.asp?reid=A3U2774687DE.

This white paper investigates the risks of vulnerable inspection practices and discusses the pros and cons of various inspection techniques including: sampling, manual inspection, mechanical sorting and optical inspection systems. The paper also suggests criteria to consider when selecting the right bulk inspection system for a given application.

Many pharmaceutical manufacturers and contract packers have historically relied on labor-intensive manual inspection. Now, advancing technology has ushered in new possibilities with continuous, fully automated bulk optical inspection systems that inspect up to one million tablets or softgel capsules per hour, as high-resolution color cameras detect the subtlest irregularities to remove defects and foreigners from the product stream. These new inspection systems are more effective and more commercially viable than ever before, and they are prompting a new debate on what it means to be diligent in pharmaceutical manufacturing and packaging operations today.

About Symetix
Symetix is the pharmaceutical business unit of Key Technology. With 60 years of experience in the food, tobacco, and pharmaceutical industries, Key is a leading manufacturer of best-in-class process automation systems. Symetix maintains demonstration and testing facilities, manufacturing, engineering, parts and service at Key’s headquarters in Walla Walla, Washington, USA. Symetix extends global support through Key Technology facilities in Beusichem, The Netherlands; Shanghai, China; Melbourne, Australia; and Santiago de Queretaro, Mexico. Key’s common stock trades on the Global Market tier of The NASDAQ Stock MarketSM under the symbol: KTEC.

[TOP]